Quantcast

Latest Dana-Farber Cancer Institute Stories

2011-12-10 01:58:40

Scientists use a micro-RNA tool to block a cancer-causing molecular circuit in liver cells Cancer of the liver — rare in the United States but the third-leading cause of cancer death worldwide — can result from environmental exposures or infections like chronic hepatitis, but the link is poorly understood. Now, researchers at Dana-Farber Cancer Institute have identified a mechanism in mice that triggers inflammation in the liver and transforms normal cells into cancerous...

2011-12-07 11:14:35

Study finds no evidence that androgen deprivation therapy causes heart attacks Hormone-blocking therapy for prostate cancer doesn't raise the risk of fatal heart attacks — as some recent studies had suggested — according to a new report from Dana-Farber/Brigham and Women's Cancer Center. For men with high-risk prostate tumors, a combination of local treatment and drugs that block male hormones that feed prostate tumors can significantly lengthen survival. In the past few...

2011-12-01 13:10:16

Study has implications for treatment of other immune-mediated disorders In a study that seems to pivot on a paradox, scientists at Dana-Farber Cancer Institute have used an immune system stimulant as an immune system suppressor to treat a common, often debilitating side effect of donor stem cell transplantation in cancer patients. The effect, in some cases, was profound. The phase I study, published in the Dec. 1 issue of the New England Journal of Medicine, involved allogeneic (donor)...

2011-12-01 10:47:45

Joslin study uncovers potential targets for treating disease Scientists at Joslin Diabetes Center in Boston have uncovered important molecular and genetic keys to the development of soft-tissue sarcomas in skeletal muscle, giving researchers and clinicians additional targets to stop the growth of these often deadly tumors. Published in the Proceedings of the National Academy of Sciences, the study identified two major molecular signaling pathways (the Ras and mTOR pathways) that are...

2011-11-24 11:18:04

2-drug combination may alleviate radiation sickness in people A combination of two drugs may alleviate radiation sickness in people who have been exposed to high levels of radiation, even when the therapy is given a day after the exposure occurred, according to a study led by scientists from Dana-Farber Cancer Institute and Children's Hospital Boston. Mouse studies of other potential therapies suggest they would be effective in humans only if administered within a few minutes or hours...

2011-11-14 08:00:00

Boston-based Internet stationery company, LookLoveSend, LLC is partnering with Dana-Farber Cancer Institute and the Jimmy Fund this holiday season to offer online access to high-quality printed, personalized holiday photo cards. The collection includes special Dana-Farber Cancer Institute photo cards, the proceeds from which will go directly to the Jimmy Fund. Shoppers may also choose to make a gift directly to the Jimmy Fund at checkout with any other holiday card purchases. Billerica, MA...

2011-10-27 22:10:00

Finding rewrites old theory of why chemo works Challenging a half-century-old theory about why chemotherapy agents target cancer, scientists at Dana-Farber Cancer Institute have devised a test that can predict how effective the drugs will be by determining whether a patient's tumor cells are already "primed" for death. In a study published online by the journal Science on Oct. 27, the researchers report that cancer cells that are on the verge of self-destruction are more likely to...


Word of the Day
mallemaroking
  • Nautical, the visiting and carousing of sailors in the Greenland ships.
This word is apparently from a confusion of two similar Dutch words: 'mallemerok,' a foolish woman, and 'mallemok,' a name for some persons among the crew of a whaling vessel.